Get Started

DMRA

NASD Damora Therapeutics, Inc.
Nov 3, 2026 · 1:11 PM ET DELAYED Market Open

$21.79 ↑ +0.19 (+0.88%) Trading Up from the previous close of $21.60, $1.08 below the day’s high of $22.87

YTD change
-14.58%
vs 20-day SMA
+6.28%
vs 200-day SMA
N/A

Price ranges

Previous day
$20.75 $21.94
open $21.75 close $21.60
-$0.15 (-0.69%)
Today
$21.76 $22.87
open $21.76 now $21.79
+$0.03 (+0.14%)
Past week
$20.23 $23.21
from $21.26 now $21.79
+$0.53 (+2.49%)
Past month
$17.49 $23.21
from $20.22 now $21.79
+$1.57 (+7.76%)
This year
$16.50 $34.89
from $25.51 now $21.79
-$3.72 (-14.58%)

Price & Performance

-4.33 (-16.70%) / 6M

$17.27$22.90$28.52$34.15May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 43.1% away from all-time highs of $38.33
  • DMRA is down 15% since the beginning of the year
  • DMRA is down 15% over the past 12 months
  • DMRA is up 8% over the past 1 month
  • 8% of all DMRA investors are betting against DMRA

DMRA reads very good: the 12-month move is -15.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.39
Earnings momentum +19.2% Quarterly EPS growth
Quarterly change +19.2%

Valuation

P/E ratio N/A
Enterprise value $910.0M
Beta 1.43

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$540.5M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.3B

Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $465.45 -0.12%
MRNA Moderna, Inc. $220.83 -0.40%
RVMD Revolution Medicines, Inc. $188.17 -1.64%
ROIV Roivant Sciences Ltd. $35.89 -2.76%
BNTX BioNTech SE Sponsored ADR $87.53 -0.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.